79
Views
13
CrossRef citations to date
0
Altmetric
Original Paper

Intratumor heterogeneity of biomarker expression in breast carcinomas

, , , , &
Pages 25-36 | Received 17 Mar 2003, Accepted 25 Mar 2003, Published online: 12 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (5)

Trine Tramm, Marianne Kyndi, Flemming B. Sørensen, Jens Overgaard & Jan Alsner. (2018) Influence of intra-tumoral heterogeneity on the evaluation of BCL2, E-cadherin, EGFR, EMMPRIN, and Ki-67 expression in tissue microarrays from breast cancer. Acta Oncologica 57:1, pages 102-106.
Read now
Ping Tang, Jianmin Wang, David G. Hicks, Xi Wang, Linda Schiffhauer, Loralee McMahon, Qi Yang, Michelle Shayne, Alissa Huston, Kristin A. Skinner, Jennifer Griggs & Gary Lyman. (2010) A Lower Allred Score for Progesterone Receptor Is Strongly Associated With a Higher Recurrence Score of 21-Gene Assay in Breast Cancer. Cancer Investigation 28:9, pages 978-982.
Read now
M. Kyndi, F. B. Sørensen, H. Knudsen, J. Alsner, M. Overgaard, H. M. Nielsen & J. Overgaard. (2008) Impact of BCL2 and p53 on postmastectomy radiotherapy response in high-risk breast cancer. A subgroup analysis of DBCG82 b&c. Acta Oncologica 47:4, pages 608-617.
Read now

Articles from other publishers (8)

Umar Mehraj, Umar Mushtaq, Manzoor A. Mir, Afnan Saleem, Muzafar A. Macha, Mohammad Nadeem Lone, Abid Hamid, Mohammed A. Zargar, Syed Mudasir Ahmad & Nissar Ahmad Wani. (2022) Chemokines in triple-negative breast cancer heterogeneity: New challenges for clinical implications. Seminars in Cancer Biology 86, pages 769-783.
Crossref
Gulisa Turashvili & Edi Brogi. (2017) Tumor Heterogeneity in Breast Cancer. Frontiers in Medicine 4.
Crossref
Susan F. Slovin. (2016) Biomarkers for immunotherapy in genitourinary malignancies. Urologic Oncology: Seminars and Original Investigations 34:4, pages 205-213.
Crossref
Katharina Mack, Ronny Rüger, Sina Fellermeier, Oliver Seifert & Roland E. Kontermann. (2012) Dual Targeting of Tumor Cells with Bispecific Single-Chain Fv-Immunoliposomes. Antibodies 1:2, pages 199-214.
Crossref
Sian M. Dibben, Robert J. Holt, Timothy S. Davison, Claire L. Wilson, Janet Taylor, Ian Paul, Kieran McManus, Paul J. Kelly, Vitali Proutski, D. Paul Harkin, Peter Kerr, Dean A. Fennell, Jacqueline A. James & Richard D. Kennedy. (2012) Implications for Powering Biomarker Discovery Studies. The Journal of Molecular Diagnostics 14:2, pages 130-139.
Crossref
Aziza Nassar, Anuradha Radhakrishnan, Isabella A. Cabrero, George A. Cotsonis & Cynthia Cohen. (2010) Intratumoral Heterogeneity of Immunohistochemical Marker Expression in Breast Carcinoma. Applied Immunohistochemistry & Molecular Morphology 18:5, pages 433-441.
Crossref
Kristina SubikJin-Feng LeeLaurie BaxterTamera StrzepekDawn CostelloPatti CrowleyLianping XingMien-Chie HungThomas BonfiglioDavid G. HicksPing Tang. (2010) The Expression Patterns of ER, PR, HER2, CK5/6, EGFR, Ki-67 and AR by Immunohistochemical Analysis in Breast Cancer Cell Lines. Breast Cancer: Basic and Clinical Research 4, pages 117822341000400.
Crossref
Joanna M. Ilvesaro, Melinda A. Merrell, Li Li, Savita Wakchoure, David Graves, Sonja Brooks, Eeva Rahko, Arja Jukkola-Vuorinen, Katri S. Vuopala, Kevin W. Harris & Katri S. Selander. (2008) Toll-Like Receptor 9 Mediates CpG Oligonucleotide–Induced Cellular Invasion. Molecular Cancer Research 6:10, pages 1534-1543.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.